Assembly Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $505.58 Millions, with shareholders equity totaling $198.61 Millions.
The company employs approximately 139 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Assembly Biosciences Inc. reported $71.10 Millions in revenue, generating net income of $-6.39 Millions.
Key financial metrics include a P/E ratio of -79.12, a price-to-book (P/B) ratio of 2.55, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ASMB.